98%
921
2 minutes
20
Background Immunoglobulin A nephropathy (IgAN) is the most common primary glomerular disease, characterized by IgA-containing immune complexes in the mesangium and mesangial cell proliferation. Proteinuria is a strong indicator of the progression of chronic kidney disease. This study aimed to evaluate the relationship between systemic inflammation markers, including the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), IgA/complement (C)3, IgA/C4, and C3/C4 ratios, and proteinuria in IgAN patients. Methods This retrospective study involved 38 patients diagnosed with IgAN between 2002 and 2011. We assessed various serum markers such as leukocyte count, NLR, PLR, C-reactive protein (CRP), C3, C4, IgA, and IgM, as well as proteinuria. The correlation between these markers and proteinuria was examined. Results The mean age of the patients was 37.8 ± 2 years, with 68.42% male. No significant correlation was found between the NLR and proteinuria (p=0.3) or CRP (p=0.3). However, a moderate positive correlation was observed between the NLR and sedimentation rate (R=0.38, p=0.07). Significant negative correlations were found between proteinuria and both urine pH (R=-0.5, p=0.002) and IgA/C4 ratio (R=-0.5, p=0.013). There were positive correlations between the PLR and C4 (R=0.45, p=0.02) and negative correlations between the PLR and IgA/C4 ratio (R=-0.56, p=0.003) and IgA/C4 and C3 (R=-0.48, p=0.008). No significant differences in proteinuria and leukocyte count were observed between the two sexes. Conclusion Although no significant relationship was found between the NLR, PLR, and proteinuria in IgAN, correlation between the IgA/C4 ratio and C4 warrants further investigations in larger studies.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11913522 | PMC |
http://dx.doi.org/10.7759/cureus.79060 | DOI Listing |
Eur J Case Rep Intern Med
August 2025
Nephrology Department, Unidade Local de Saúde de Braga, Braga, Portugal.
Introduction: Bevacizumab is a monoclonal antibody that targets vascular endothelial growth factor (VEGF) and is widely used in oncology for its anti-angiogenic properties. However, VEGF inhibition may result in significant nephrotoxicity, including thrombotic microangiopathy (TMA). While systemic TMA is well-described, isolated renal-limited TMA remains under recognised.
View Article and Find Full Text PDFEur J Case Rep Intern Med
August 2025
Department of Internal Medicine, Western Michigan University Homer Stryker M.D. School of Medicine, Kalamazoo, USA.
Unlabelled: Autoimmune haemolytic anaemia (AIHA) is caused by antibody-mediated destruction of red blood cells. There are two broad categories of AIHA: warm and cold, both categorized by the thermal reactivity of the autoantibodies. Cold agglutinin disease (CAD) occurs at temperatures below normal body temperature and primarily involves IgM antibodies.
View Article and Find Full Text PDFFront Pediatr
August 2025
Department of Rheumatology and Immunology, Tianjin Children's Hospital (Children's Hospital, Tianjin University), Tianjin Key Laboratory of Birth Defects for Prevention and Treatment, Tianjin, China.
Type 1 diabetes mellitus (T1DM) and systemic lupus erythematosus (SLE) are both autoimmune diseases influenced by multiple genetic and environmental factors, but rarely coexist. This case describes a 13-year-old girl with early onset of T1DM who was diagnosed with SLE 12 years later, highlighting diagnostic and therapeutic challenges, particularly in distinguishing kidney involvement and management without exacerbating hyperglycemia. The patient presented with edema of the eyelids and lower limbs.
View Article and Find Full Text PDFMedComm (2020)
September 2025
Immunoglobulin A nephropathy (IgAN), the most prevalent primary glomerulonephritis globally, is characterized by mesangial IgA deposition and heterogeneous clinical trajectories. Historically, management relied on renin-angiotensin system inhibition and empirical immunosuppression, yet high lifetime kidney failure risk persists despite optimized care. This review synthesizes advances in molecular pathogenesis, highlighting how the traditional multi-hit hypothesis-while foundational for targeted therapy development-fails to capture IgAN's recurrent, self-amplifying nature.
View Article and Find Full Text PDFClin Kidney J
September 2025
Hypertension is a pervasive and progressive complication in chronic kidney disease (CKD) patients, affecting up to 90% of those in advanced stages or on dialysis. A particularly insidious aspect of this condition is nocturnal hypertension, characterized by high blood pressure (BP) during sleep and a blunted or absent nighttime BP dipping-phenomena associated with accelerated CKD progression and increased cardiovascular risk. Despite its strong prognostic significance, nocturnal hypertension remains underdiagnosed due to limited use of ambulatory BP monitoring.
View Article and Find Full Text PDF